Evidence 1
Activity
Activity
10% Hemolysis
Toxicity
110 µM
Hemolytic
Cytotoxic
10% Hemolysis | 110 | µM | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Bioengineering and functional characterization of arenicin shortened analogs with enhanced antibacterial activity and cell selectivity. | J Pept Sci | 2016